Therapy Areas: Diabetes
14 June 2024 - In-vitro diagnostics and laboratory services company Renalytix plc (NASDAQ:RNLX) (LSE:RENX) announced on Friday Medicare's final coverage determination for its kidney disease test,...
12 June 2024 - Innovent Biologics Inc (HKEX: 01801), a biopharmaceutical company that develops, manufactures and commercialises medicines for the treatment of oncology, autoimmune, cardiovascular and ...
17 April 2024 - Biopharmaceutical company GSK plc (LSE/NYSE:GSK) on Wednesday announced positive data from the ZOSTER-049 long-term follow-up phase III trial, spanning up to approximately 11 years pos...
10 April 2024 - Amylyx Pharmaceuticals (NASDAQ: AMLX), a developer of new treatments for neurodegenerative disease, on Wednesday released interim data from Phase 2 HELIOS trial showing improvements in...
9 April 2024 - Biopharmaceutical company Pfizer Inc (NYSE:PFE) on Tuesday announced positive top-line data from the Phase 3 MONeT trial evaluating ABRYSVO in adults aged 18-59 at risk of developing se...
21 March 2024 - Clinical stage medical sensor company Lifecare AS (Euronext Growth Oslo:LIFE) said on Thursday that it has received notification from the European Patent Office (EPO) that it will gran...